Precigen (PGEN) Current Deferred Revenue (2012 - 2026)

Precigen (PGEN) has 15 years of Current Deferred Revenue data on file, last reported at $410000.0 in Q1 2026.

• On a quarterly basis, Current Deferred Revenue fell 82.81% year-over-year to $410000.0 in Q1 2026; TTM through Mar 2026 was $410000.0, a 82.81% decrease from a year earlier, with the FY2025 full-year figure at $517000.0, down 12.22% from the prior year.
• Current Deferred Revenue for Q1 2026 stood at $410000.0, down from $517000.0 in the prior quarter.
• Over the last five years, Current Deferred Revenue for PGEN reached as high as $2.7 million in Q1 2022 and fell as low as $15000.0 in Q2 2023.
• Historically, Current Deferred Revenue has averaged $1.0 million across 5 years, with a median of $509000.0 in 2023.
• Across the five-year window, Current Deferred Revenue slumped 99.9% in 2022 and soared 2420.0% in 2024, its largest moves.
• Year by year, Current Deferred Revenue stood at $25000.0 in 2022, then surged by 1936.0% to $509000.0 in 2023, then climbed by 15.72% to $589000.0 in 2024, then decreased by 12.22% to $517000.0 in 2025, then retreated by 20.7% to $410000.0 in 2026.
• Per Business Quant data, the three most recent Current Deferred Revenue figures were $410000.0 in Q1 2026, $517000.0 in Q4 2025, and $480000.0 in Q3 2025.